BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bourgeois DL, Kabarowski KA, Porubsky VL, Kreeger PK. High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation. Cancer Cell Int 2015;15:112. [PMID: 26648788 DOI: 10.1186/s12935-015-0263-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Chehade H, Tedja R, Ramos H, Bawa TS, Adzibolosu N, Gogoi R, Mor G, Alvero AB. Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression. Cancers 2022;14:2267. [DOI: 10.3390/cancers14092267] [Reference Citation Analysis]
2 Bae H, Park S, Ham J, Song J, Hong T, Choi JH, Song G, Lim W. ER-Mitochondria Calcium Flux by β-Sitosterol Promotes Cell Death in Ovarian Cancer. Antioxidants (Basel) 2021;10:1583. [PMID: 34679718 DOI: 10.3390/antiox10101583] [Reference Citation Analysis]
3 Yee SS, Risinger AL. Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models. Molecules 2021;26:4077. [PMID: 34279417 DOI: 10.3390/molecules26134077] [Reference Citation Analysis]
4 Yeku OO, Rao TD, Laster I, Kononenko A, Purdon TJ, Wang P, Cui Z, Liu H, Brentjens RJ, Spriggs D. Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition. Front Immunol 2021;12:663379. [PMID: 33936101 DOI: 10.3389/fimmu.2021.663379] [Reference Citation Analysis]
5 Robinson M, Gilbert SF, Waters JA, Lujano-Olazaba O, Lara J, Alexander LJ, Green SE, Burkeen GA, Patrus O, Sarwar Z, Holmberg R, Wang C, House CD. Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells. Cancers (Basel) 2021;13:E262. [PMID: 33445692 DOI: 10.3390/cancers13020262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lee E, Lokman NA, Oehler MK, Ricciardelli C, Grutzner F. A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer. Cancers (Basel) 2020;13:E4. [PMID: 33374923 DOI: 10.3390/cancers13010004] [Reference Citation Analysis]
7 Fagerholt OHE, Hellesøy M, Gullaksen SE, Gjertsen BT. Single Cell Detection of the p53 Protein by Mass Cytometry. Cancers (Basel) 2020;12:E3699. [PMID: 33317179 DOI: 10.3390/cancers12123699] [Reference Citation Analysis]
8 Fogg KC, Miller AE, Li Y, Flanigan W, Walker A, O'Shea A, Kendziorski C, Kreeger PK. Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway. BMC Cancer 2020;20:1008. [PMID: 33069212 DOI: 10.1186/s12885-020-07513-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Fogg KC, Renner CM, Christian H, Walker A, Marty-Santos L, Khan A, Olson WR, Parent C, O'Shea A, Wellik DM, Weisman PS, Kreeger PK. Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases. Tissue Eng Part A 2020;26:747-58. [PMID: 32598229 DOI: 10.1089/ten.tea.2020.0001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells 2019;9:E19. [PMID: 31861708 DOI: 10.3390/cells9010019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Fogg KC, Olson WR, Miller JN, Khan A, Renner C, Hale I, Weisman PS, Kreeger PK. Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway. Cancer Lett 2019;458:92-101. [PMID: 31129149 DOI: 10.1016/j.canlet.2019.05.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
12 Kopper O, de Witte CJ, Lõhmussaar K, Valle-Inclan JE, Hami N, Kester L, Balgobind AV, Korving J, Proost N, Begthel H, van Wijk LM, Revilla SA, Theeuwsen R, van de Ven M, van Roosmalen MJ, Ponsioen B, Ho VWH, Neel BG, Bosse T, Gaarenstroom KN, Vrieling H, Vreeswijk MPG, van Diest PJ, Witteveen PO, Jonges T, Bos JL, van Oudenaarden A, Zweemer RP, Snippert HJG, Kloosterman WP, Clevers H. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med 2019;25:838-49. [PMID: 31011202 DOI: 10.1038/s41591-019-0422-6] [Cited by in Crossref: 179] [Cited by in F6Publishing: 172] [Article Influence: 59.7] [Reference Citation Analysis]
13 Tang MKS, Yue PYK, Ip PP, Huang RL, Lai HC, Cheung ANY, Tse KY, Ngan HYS, Wong AST. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface. Nat Commun. 2018;9:2270. [PMID: 29891938 DOI: 10.1038/s41467-018-04695-7] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 19.5] [Reference Citation Analysis]
14 Carroll MJ, Kapur A, Felder M, Patankar MS, Kreeger PK. M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop. Oncotarget 2016;7:86608-20. [PMID: 27888810 DOI: 10.18632/oncotarget.13474] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
15 Hassan W, Chitcholtan K, Sykes P, Garrill A. Ascitic fluid from advanced ovarian cancer patients compromises the activity of receptor tyrosine kinase inhibitors in 3D cell clusters of ovarian cancer cells. Cancer Lett 2018;420:168-81. [PMID: 29432847 DOI: 10.1016/j.canlet.2018.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Xie S, Wang X, Ren H, Liu X, Ren J, Liu W. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma. Acta Otolaryngol 2017;137:797-802. [PMID: 28498080 DOI: 10.1080/00016489.2017.1284343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Varas-Godoy M, Rice G, Illanes SE. The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment. Stem Cells Int 2017;2017:5263974. [PMID: 28819364 DOI: 10.1155/2017/5263974] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
18 Bordeleau F, Reinhart-King CA. Tuning cell migration: contractility as an integrator of intracellular signals from multiple cues. F1000Res 2016;5:F1000 Faculty Rev-1819. [PMID: 27508074 DOI: 10.12688/f1000research.7884.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]